Artículos por temáticas

Warming needle moxibustion for Alzheimer's disease: A systematic review of randomized controlled trials

Chen X, Liu F, Lin N, Lin Q, Lyu Z, Xiu H, Nie P.

Geriatr Nurs. 2022 Jan-Feb;43:219-226. doi: 10.1016/j.gerinurse.2021.12.004.

Myelin repair in Alzheimer's disease: a review of biological pathways and potential therapeutics

Hirschfeld LR, Risacher SL, Nho K, Saykin AJ.

Transl Neurodegener. 2022 Oct 26;11(1):47. doi: 10.1186/s40035-022-00321-1.

Effects of interventions on cerebral perfusion in the Alzheimer's disease spectrum: A systematic review

Marcolini S, Frentz I, Sanchez-Catasus CA, Mondragon JD, Feltes PK, van der Hoorn A, Borra RJH, Ikram MA, Dierckx RAJO, De Deyn PP.

Ageing Res Rev. 2022 Aug;79:101661. doi: 10.1016/j.arr.2022.101661. Epub 2022 Jun 4.

Is non-invasive brain stimulation effective for cognitive enhancement in Alzheimer's disease? An updated meta-analysis

Šimko P, Kent JA, Rektorova I.

Clin Neurophysiol. 2022 Dec;144:23-40. doi: 10.1016/j.clinph.2022.09.010. Epub 2022 Sep 28.

Resolvins Lipid Mediators: Potential Therapeutic Targets in Alzheimer and Parkinson Disease

Anand S, Azam Ansari M, Kumaraswamy Sukrutha S, Alomary MN, Anwar Khan A, Elderdery AY.

Neuroscience. 2022 Dec 15;507:139-148. doi: 10.1016/j.neuroscience.2022.11.001. Epub 2022 Nov 11.

Selected Natural Products in Neuroprotective Strategies for Alzheimer's Disease-A Non-Systematic Review

Wojtunik-Kulesza K, Oniszczuk T, Mołdoch J, Kowalska I, Szponar J, Oniszczuk A.

Int J Mol Sci. 2022 Jan 21;23(3):1212. doi: 10.3390/ijms23031212.

Roles of Cannabidiol in the Treatment and Prevention of Alzheimer's Disease by Multi-target Actions

Zhang XB, Li J, Gu J, Zeng YQ.

Mini Rev Med Chem. 2022;22(1):43-51. doi: 10.2174/1389557521666210331162857.

Disease-Modifying Effects of Non-Invasive Electroceuticals on β-Amyloid Plaques and Tau Tangles for Alzheimer's Disease

Bok J, Ha J, Ahn BJ, Jang Y.

Int J Mol Sci. 2022 Dec 30;24(1):679. doi: 10.3390/ijms24010679.

The Current Landscape of Prevention Trials in Dementia

Lee J, Howard RS, Schneider LS.

Neurotherapeutics. 2022 Jan;19(1):228-247. doi: 10.1007/s13311-022-01236-5. Epub 2022 May 19.

Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease

Bateman RJ, Cummings J, Schobel S, Salloway S, Vellas B, Boada M, Black SE, Blennow K, Fontoura P, Klein G, Assunção SS, Smith J, Doody RS.

Alzheimers Res Ther. 2022 Nov 29;14(1):178. doi: 10.1186/s13195-022-01110-8.

Disease-Modifying Activity of Huperzine A on Alzheimer's Disease: Evidence from Preclinical Studies on Rodent Models

Yan YP, Chen JY, Lu JH.

Int J Mol Sci. 2022 Dec 3;23(23):15238. doi: 10.3390/ijms232315238.

BACE1: A Key Regulator in Alzheimer's Disease Progression and Current Development of its Inhibitors

Patel S, Bansoad AV, Singh R, Khatik GL.

Curr Neuropharmacol. 2022;20(6):1174-1193. doi: 10.2174/1570159X19666211201094031.

Clinical Research Investigating Alzheimer's Disease in China: Current Status and Future Perspectives Toward Prevention

Wang Q, Gao F, Dai LN, Zhang J, Bi D, Shen Y.

J Prev Alzheimers Dis. 2022;9(3):532-541. doi: 10.14283/jpad.2022.46.

Recruitment and Screening Methods in Alzheimer's Disease Research: The FIT-AD Trial

Greimel S, Wyman JF, Zhang L, Yu F.

J Gerontol A Biol Sci Med Sci. 2022 Mar 3;77(3):547-553. doi: 10.1093/gerona/glab092.

Ketogenic Diet: A Promising Neuroprotective Composition for Managing Alzheimer's Diseases and its Pathological Mechanisms

Sridharan B, Lee MJ.

Curr Mol Med. 2022;22(7):640-656. doi: 10.2174/1566524021666211004104703.